WHO Study Finds No Benefit From Four Drugs Being Evaluated To Treat COVID-19

CIDRAP (12/3, Van Beusekom) reports, “None of the four once-promising drugs evaluated for the treatment of COVID-19 in the ongoing World Health Organization (WHO) Solidarity Trial – remdesivir, hydroxychloroquine, lopinavir, or interferon-beta-1a – preven...